Reversible neurological deficit after foam sclerotherapy.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 19683463.
- Also identified by DOI 10.1016/j.ejvs.2009.06.022.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
A 37-year-old male was treated with 9 ml of 3% polidocanol foam, and he immediately reported photopsiae lasting a few minutes, though without migraine. Two hours after sclerotherapy, the patient developed speech disturbance for a few minutes. A pathological examination revealed nothing except a patent foramen ovale (PFO). Given the contrast between the high prevalence of PFO in general population and the extremely low incidence of neurological deficits after foam sclerotherapy, these deficits may only arise due to as-yet-unknown aetiology.
Medical subject headings
- Polyethylene Glycols
- Sclerosing Solutions
- Sclerotherapy
- Speech Disorders
- Varicose Veins
- Vision Disorders